Last reviewed · How we verify
NCT07371507
Effect of a Health Education Program on Teachers' Antibiotic Use Practices
NA trial testing Behavioral in Antibiotic Resistance Prevention in 106 participants. Completed in 1 July 2025.
1 May 2025
Quick facts
| Lead sponsor | Hawler Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 106 |
| Start date | 1 September 2024 |
| Primary completion | 1 May 2025 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Behavioral
Conditions studied
- Antibiotic Resistance Prevention — all drugs for Antibiotic Resistance Prevention →
Sponsor
Hawler Medical University
Who can join
22 and older, any sex, with Antibiotic Resistance Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Antibiotic resistance is a growing public health problem caused in part by inappropriate use of antibiotics. Teachers play an important role in shaping health knowledge and behaviors within schools and communities. This study evaluates the effect of a structured health education program on teachers' antibiotic use practices among high school teachers in the Koya District, Erbil City, Iraq. In this randomized controlled trial, eligible teachers were assigned to either an intervention group that received a targeted health education program on appropriate antibiotic use and resistance prevention, or a control group that did not receive the program during the study period. Teachers' antibiotic use practices were assessed before and after the intervention using a structured questionnaire. The goal of this study is to determine whether a health education program can improve responsible antibiotic use practices and reduce behaviors that contribute to antibiotic resistance. The findings may help inform future school-based health education strategies aimed at preventing antibiotic resistance at the community level.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07371507
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Behavioral
Trials testing the same drug.
- NCT06687317 — Reliabılıty,Validity Of The Turkish Version Of The KNAP · not yet recruiting
- NCT06044571 — Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults · NA · recruiting
- NCT05413278 — Targeted Interventions for Successful Transition and Transfer of Adolescents With Inborn Errors of Metabolism to Adult S · NA · recruiting
- NCT06239246 — Association Between Cardiovascular Diseases and Mental Illness · completed
- NCT05861232 — The Effect of Watching Informative Animation on Fear and Anxiety in Children · NA · unknown
Other Hawler Medical University trials
Trials by the same sponsor.
- NCT07066930 — Optimizing Alveolar Ridge Expansion · NA · not yet recruiting
- NCT07047742 — Efficacy of Dietary Interventions and Educational Programs as Adjunctive Therapies for the Management of Urolithiasis: E · NA · not yet recruiting
- NCT07467616 — Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis. · NA · completed
- NCT07380776 — Preoperative Education Program on Gastrointestinal Quality of Life in Cholecystectomy Patients · NA · active not recruiting
- NCT06642337 — Nutritional Educational Program On Therapy in Iron Deficiency Anemia · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07371507 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hawler Medical University
- Last refreshed: 3 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07371507.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing